✦ LIBER ✦

Gefitinib versus docetaxel in previously treated advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials

✍ Scribed by Jiang, Jingwei; Huang, Lizhen; Liang, Xiaohua; Zhou, Xinli; Huang, Ruofan; Chu, Zhaohui; Zhan, Qiong

Book ID: 120384561
Publisher: Informa plc
Year: 2010
Tongue: English
Weight: 142 KB
Volume: 50
Category: Article
ISSN: 0284-186X
DOI: 10.3109/0284186X.2010.546368

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gefitinib versus docetaxel in previously

Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial

✍ Edward S Kim; Vera Hirsh; Tony Mok; Mark A Socinski; Radj Gervais; Yi-Long Wu; L 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 243 KB

A Randomized Phase II Study of Gefitinib

A Randomized Phase II Study of Gefitinib Plus Simvastatin Versus Gefitinib Alone in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

✍ Han, J.-Y.; Lee, S.-H.; Yoo, N. J.; Hyung, L. S.; Moon, Y. J.; Yun, T.; Kim, H. 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 317 KB

Review of two phase III randomized trial

Review of two phase III randomized trials of single-agent docetaxel in previously treated advanced non-small cell lung cancer

✍ Thomas J Lynch Jr 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 515 KB

Multi-Institutional Randomized Phase II

Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer

✍ Fukuoka, M. 📂 Article 📅 2003 🏛 American Society of Clinical Oncology 🌐 English ⚖ 300 KB

Icotinib versus gefitinib in previously

Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial

✍ Shi, Yuankai; Zhang, Li; Liu, Xiaoqing; Zhou, Caicun; Zhang, Li; Zhang, Shucai; 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 490 KB

Randomized Phase III Trial of Gefitinib

Randomized Phase III Trial of Gefitinib versus Docetaxel in Non-Small Cell Lung Cancer Patients Who Have Previously Received Platinum-Based Chemotherapy

✍ Lee, D. H.; Park, K.; Kim, J. H.; Lee, J.-S.; Shin, S. W.; Kang, J.-H.; Ahn, M.- 📂 Article 📅 2010 🏛 American Association for Cancer Research 🌐 English ⚖ 305 KB